Group III (10 patients) received oral placebo capsules (as a control) once daily for 4 weeks
Wegovy clinical studies and reported hair loss percentages Wegovy clinical trials show more notable results: Hair loss affected 3% of adult participants compared to 1% in the placebo group [7] The numbers were higher in children 12 and older, where 4% reported hair loss while the placebo group showed no cases [8] Comparing hair loss rates across different GLP-1 medications GLP-1 medications of all types show distinct patterns: Tirzepatide (Mounjaro): Users reported hair loss rates between 4.9% to 5.7% at doses from 5mg to 15mg [8] Zepbound: The overall rates reached 4% to 5%, with women showing much higher numbers 7.1% compared to just 0.5% in men [8] Research from the University of British Columbia shows that people who use semaglutide have a 52% higher chance of hair loss compared to those taking older weight loss medications [9]

CrossRef LPCAT3 deficiency Drives phospholipid remodeling and mitochondrial oxidative dysfunction to accelerate MASH-HCC development Gaoxuan Shao, Chenhao Ye, Chenceng Sun, Jiashu Pan, Lu Lu, Lei Wang, Tao Wu, Zemin Lin, Guang Ji, Hanchen Xu Journal of Advanced Research .2026;[Epub] CrossRef Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies Eleni A
Your prescription should tell you: how many milligrams of medicine you want to inject each time or how much volume of medicine to inject each time or both If you need to figure out how much liquid to inject to get the right dose, divide the mg you want (Dosage) by the mg (Strength) in the solution, and multiply it by the per mL (Concentration) in the vial
Available from: Accessed 9 Nov 2023 Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al
Nishizawa, M., Nakabayashi, H., Uchida, K., Nakagawa, A